AAAAAA
Results:
1-14
|
Results: 14
Authors:
Latchman, Y
Wood, CR
Chernova, T
Chaudhary, D
Borde, M
Chernova, I
Iwai, Y
Long, AJ
Brown, JA
Nunes, R
Greenfield, EA
Bourque, K
Boussiotis, VA
Carter, LL
Carreno, BM
Malenkovich, N
Nishimura, H
Okazaki, T
Honjo, T
Sharpe, AH
Freeman, GJ
Citation: Y. Latchman et al., PD-L2 is a second ligand for PD-I and inhibits T cell activation, NAT IMMUNOL, 2(3), 2001, pp. 261-268
Authors:
Tzachanis, D
Freeman, GJ
Hirano, N
van Puijenbroek, AAFL
Delfs, MW
Berezovskaya, A
Nadler, LM
Boussiotis, VA
Citation: D. Tzachanis et al., Tob is a negative regulator of activation that is expressed in anergic andquiescent T cells, NAT IMMUNOL, 2(12), 2001, pp. 1174-1182
Authors:
Greenwald, RJ
Boussiotis, VA
Lorsbach, RB
Abbas, AK
Sharpe, AH
Citation: Rj. Greenwald et al., CTLA-4 regulates induction of anergy in vivo, IMMUNITY, 14(2), 2001, pp. 145-155
Authors:
Appleman, LJ
Tzachanis, D
Grader-Beck, T
van Puijenbroek, AAFL
Boussiotis, VA
Citation: Lj. Appleman et al., Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics, J MOL MED-J, 78(12), 2001, pp. 673-683
Authors:
Barata, JT
Cardoso, AA
Nadler, LM
Boussiotis, VA
Citation: Jt. Barata et al., Interleukin-7 promotes survival and cell cycle progression of T-cell acutelymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p(27kip1), BLOOD, 98(5), 2001, pp. 1524-1531
Authors:
Boussiotis, VA
Chen, ZM
Zeller, JC
Murphy, WJ
Berezovskaya, A
Narula, S
Roncarolo, MG
Blazar, BR
Citation: Va. Boussiotis et al., Altered T-cell receptor+CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease, BLOOD, 97(2), 2001, pp. 565-571
Authors:
Boussiotis, VA
Freeman, GJ
Taylor, PA
Berezovskaya, A
Grass, I
Blazar, BR
Nadler, LM
Citation: Va. Boussiotis et al., p27(kip1) functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes, NAT MED, 6(3), 2000, pp. 290-297
Authors:
Angelopoulou, MK
Vassilakopoulos, TP
Siakantaris, MP
Kontopidou, FN
Boussiotis, VA
Papavassiliou, C
Kittas, C
Pangalis, GA
Citation: Mk. Angelopoulou et al., EBVD combination chemotherapy plus low dose involved field radiation is a highly effective treatment modality for early stage Hodgkin's disease, LEUK LYMPH, 37(1-2), 2000, pp. 131-143
Authors:
McAdam, AJ
Chang, TT
Lumelsky, AE
Greenfield, EA
Boussiotis, VA
Duke-Cohan, JS
Chernova, T
Malenkovich, N
Jabs, C
Kuchroo, VK
Ling, V
Collins, M
Sharpe, AH
Freeman, GJ
Citation: Aj. Mcadam et al., Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4(+) T cells, J IMMUNOL, 165(9), 2000, pp. 5035-5040
Authors:
Appleman, LJ
Berezovskaya, A
Grass, I
Boussiotis, VA
Citation: Lj. Appleman et al., CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression, J IMMUNOL, 164(1), 2000, pp. 144-151
Authors:
Boussiotis, VA
Tsai, EY
Yunis, EJ
Thim, S
Delgado, JC
Dascher, CC
Berezovskaya, A
Rousset, D
Reynes, JM
Goldfeld, AE
Citation: Va. Boussiotis et al., IL-10-producing T cells suppress immune responses in anergic tuberculosis patients, J CLIN INV, 105(9), 2000, pp. 1317-1324
Authors:
Boussiotis, VA
Freeman, GJ
Nadler, LM
Citation: Va. Boussiotis et al., Adhesion and costimulatory molecules, CURR MOLEC, 2000, pp. 87-108
Authors:
Boussiotis, VA
Freedman, AS
Nadler, LM
Citation: Va. Boussiotis et al., Bone marrow transplantation for low-grade lymphoma and chronic lymphocyticleukemia, SEM HEMATOL, 36(2), 1999, pp. 209-216
Authors:
Guinan, EC
Boussiotis, VA
Neuberg, D
Brennan, LL
Hirano, N
Nadler, LM
Gribben, JG
Citation: Ec. Guinan et al., Transplantation of anergic histoincompatible bone marrow allografts, N ENG J MED, 340(22), 1999, pp. 1704-1714
Risultati:
1-14
|